Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

For a Healthier Europe

ESMO Director of Public Policy, Professor Jean-Yves Blay, speaks to leading media outlet Euractiv ahead of the EU 2024 elections about the role of oncologists in delivering Europe’s Beating Cancer Plan during the new EU mandate and the upcoming Hungarian EU Presidency
13 Jun 2024

Against the backdrop of the 2024 European Elections, and to mark the European Week Against Cancer (EWAC), which takes place between 25 and 31 May each year, Professor Jean-Yves Blay gave an interview to one of the leading Brussels media outlets - Euractiv - and outlined how medical oncologists’ expertise can help to optimise Europe’s Beating Cancer Plan (EBCP) to effectively tackle the scourge of cancer and achieve optimal cancer care for all in conjunction with the organisation’s priority areas listed in the ESMO’s Manifesto for a Healthier Europe, including prevention, patients’ rights and research with an increased budget of the future research programme with specific provisions for rare cancers, personalised cancer therapies, and use of AI to support clinical decision-making.

Professor Blay addressed the importance of rare cancers, including particular challenges of diagnosis and treatment of rare cancers to be tackled through greater cooperation at the EU level, with the support of the ESMO Rare Cancers Working Group, as it is recognised that progress has been made in the current mandate, however the BCP does not have a dedicated action area for rare cancers.

The interview precedes a call by ESMO on the forthcoming Hungarian Presidency of the EU, which will start on 1 July 2024, to address Europe’s cancer burden when presiding over the Council of the EU. Specifically, the Society recommended action to support the oncology workforce, enhance cancer research through the upcoming 10th EU Framework Programme, improve vaccination against cancer-causing viruses, and reduce tobacco consumption in Europe.

ESMO is committed to working with the new EU legislature on the implementation of the EBCP and achieving the best possible care for patients with cancer.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.